Milestone Medical, Inc. Stock price

Equities

MMD

USU6005B1045

Biotechnology & Medical Research

End-of-day quote Warsaw S.E. 06:00:00 2023-12-17 pm EST 5-day change 1st Jan Change
1.58 PLN -.--% Intraday chart for Milestone Medical, Inc. -.--% -.--%
Sales 2021 152K 609K Sales 2022 52.75K 211K Capitalization 8.09M 32.37M
Net income 2021 -4M -16M Net income 2022 -4M -16M EV / Sales 2021 247 x
Net Debt 2021 21.28M 85.14M Net Debt 2022 25.52M 102M EV / Sales 2022 637 x
P/E ratio 2021
-3.88 x
P/E ratio 2022
-1.66 x
Employees 12
Yield 2021 *
-
Yield 2022
-
Free-Float 1.67%
More Fundamentals * Assessed data
Dynamic Chart
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Milestone Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Milestone Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Milestone Medical, Inc. Auditor Raises 'Going Concern' Doubt CI
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Milestone Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Milestone Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Milestone Medical, Inc. Auditor Raises 'Going Concern' Doubt CI
Milestone Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Milestone Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Milestone Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Milestone Appoints Andy Johnson to Director of Enterprise Solutions CI
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
More news
1 year
1.43
Extreme 1.43
2.74
3 years
1.43
Extreme 1.43
10.20
5 years
1.43
Extreme 1.43
14.50
10 years
0.16
Extreme 0.16
14.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 21-05-18
Chief Tech/Sci/R&D Officer 63 11-02-28
Corporate Officer/Principal 78 -
Members of the board TitleAgeSince
Director/Board Member 59 13-08-31
Director/Board Member 80 14-08-31
More insiders
Milestone Medical, Inc. develops epidural and intra-articular drug delivery systems based on patented, painless, computer-controlled injection and drug delivery technology. Its CompuFlo Epidural System provides anesthesiologists and other health care providers with the ability to determine and document the pressure at the needle tip in real-time. Its CompuFlo Epidural's DPS Dynamic Pressure Sensing Technology (DPS) allows the CompuFlo Epidural to provide objective visual and audible in-tissue pressure feedback that allows anesthesiologists to identify the epidural space. The DPS instrument is a patented computer-controlled injection system geared to the needs of the medical market. The Company's is also focused on marketing the Epidural medical and trainer instruments in the United States. The Company's products include medical instruments, handpieces/disposables, and other related products. It sells its products primarily through medical facilities and a global distribution network.
More about the company
  1. Stock
  2. Equities
  3. Stock Milestone Medical, Inc. - Warsaw S.E.